Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS.
Saved in:
| Title: | Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS. |
|---|---|
| Authors: | Koch MW; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada., Camara-Lemarroy C; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada., Strijbis E; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands., Mostert J; Department of Neurology, Rijnstate Hospital, Arnhem, The Netherlands., Leavitt VM; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA., Repovic P; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, USA., Bowen JD; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, USA., Comtois J; Department of Medicine, Neurology Service, Hôpital de la Cité-de-la-Santé, Laval, QC, Canada., Uitdehaag B; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands., Cutter G; Department of Biostatistics, The University of Alabama at Birmingham, Birmingham, AL, USA. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Dec; Vol. 30 (5_suppl), pp. 41-47. Date of Electronic Publication: 2024 Sep 08. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-0970 |
|---|---|
| DOI: | 10.1177/13524585241274620 |
